{"id":177197,"date":"2026-08-13T08:50:06","date_gmt":"2026-08-13T08:50:06","guid":{"rendered":"https:\/\/pabau.com\/?p=177197"},"modified":"2026-08-13T08:50:08","modified_gmt":"2026-08-13T08:50:08","slug":"hcpcs-code-j0895","status":"publish","type":"post","link":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/","title":{"rendered":"HCPCS Code J0895: Injection, deferoxamine mesylate, 500 mg"},"content":{"rendered":"\n<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"MedicalWebPage\",\"headline\":\"HCPCS Code J0895: Injection, deferoxamine mesylate, 500 mg\",\"description\":\"HCPCS Code J0895 (Injection, deferoxamine mesylate, 500 mg) billing reference: Medicare reimbursement rates, ICD-10 pairings, modifiers, buy-and-bill workflow, and denial prevention.\",\"url\":\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j0895\/\",\"audience\":{\"@type\":\"MedicalAudience\",\"audienceType\":\"Clinician\"},\"reviewedBy\":{\"@type\":\"Person\",\"name\":\"Dr Vanja Kitanova\",\"jobTitle\":\"Medical Reviewer\",\"affiliation\":{\"@type\":\"Organization\",\"name\":\"Pabau\"},\"knowsAbout\":[\"Medical Coding\",\"Clinical Documentation\",\"Healthcare Billing\",\"Clinical Safety\"],\"sameAs\":\"https:\/\/pabau.com\/blog\/author\/vanja\/\"},\"datePublished\":\"2026-08-08\",\"dateModified\":\"2026-08-13\"}<\/script>\n\n\n        <div id=\"key_takeaways\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/12\/Key-Takeaways-Icon.svg\" alt=\"Key takeaways\" height=\"42\" width=\"42\">\n                                <h3>Key takeaways<\/h3>\n            <\/div>\n            <div class=\"list\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>HCPCS Code J0895 is the J-code for injection of deferoxamine mesylate, 500 mg, a physician-administered iron chelator.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>One unit equals 500 mg, so a 1,500 mg dose bills as 3 units, and fractional units round up rather than down.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Deferoxamine ships in single-dose vials, so every claim line needs either the JW or the JZ modifier.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Medicare covers iron overload and transfusion-dependent thalassemia, and excludes chelation therapy for cardiovascular disease.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Pair the route with its administration code: JA and CPT 96365 for IV, JB and CPT 96369 for the overnight pump.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<p class=\"wp-block-paragraph\">HCPCS Code J0895 is the billing code for an injection of deferoxamine mesylate, 500 mg. One unit equals 500 mg of drug administered, so the dose drives the unit count on every claim.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Deferoxamine is an iron chelator, and payers cover it for a narrow list of iron overload diagnoses. Medicare pays it under Part B at ASP plus 6%, and excludes chelation for cardiovascular disease outright.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This reference covers code metadata, covered ICD-10 diagnoses, fee schedule rates, and modifiers. It also walks the buy-and-bill workflow, the NDC crosswalk, and the documentation payers ask for.<\/p>\n\n\n\n<h2 id=\"h-what-hcpcs-code-j0895-covers\" class=\"wp-block-heading\">What HCPCS Code J0895 covers<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">HCPCS Code J0895 sits in the HCPCS Level II code set, which the Centers for Medicare and Medicaid Services (CMS) maintains. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">J-codes cover drugs given by routes other than oral, including intravenous infusion and subcutaneous injection. One billing unit of J0895 is 500 mg of deferoxamine mesylate.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4;min-width:180px\">Field<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">HCPCS Code<\/td>\n<td style=\"padding:12px 16px;color:#374151\">J0895<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Full descriptor<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Injection, deferoxamine mesylate, 500 mg<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code type<\/td>\n<td style=\"padding:12px 16px;color:#374151\">HCPCS Level II J-code for drug injection<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Billing unit<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Per 500 mg administered<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Maintaining body<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Centers for Medicare and Medicaid Services (CMS)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Route of administration<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Intravenous (IV) infusion or subcutaneous infusion<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Container type<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Single-dose vial, so JW or JZ is required on the claim line<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Medicare payment method<\/td>\n<td style=\"padding:12px 16px;color:#374151\">ASP plus 6%, based on Average Sales Price and updated quarterly<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<h2 id=\"h-what-deferoxamine-mesylate-treats\" class=\"wp-block-heading\">What deferoxamine mesylate treats<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Deferoxamine mesylate is an iron-chelating agent. The FDA approves it for chronic iron overload from transfusion-dependent anemia and for acute iron intoxication.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">It binds free iron in the bloodstream and forms a water-soluble complex called ferrioxamine, which the body clears through urine and feces. Practices running chelation protocols will know it as the generic form of Desferal, the Novartis brand.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The drug goes in as a slow IV infusion over 8 to 24 hours, or through a subcutaneous pump overnight. That route choice decides which administration code and which modifier belong on the claim.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4;min-width:200px\">Drug attribute<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Generic name<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Deferoxamine mesylate<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Brand name<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Desferal (Novartis); generic also available<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Drug class<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Iron chelating agent<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">FDA-approved indications<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Chronic iron overload from transfusion-dependent anemia, including thalassemia; acute iron intoxication<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Standard formulation<\/td>\n<td style=\"padding:12px 16px;color:#374151\">500 mg powder vial for reconstitution<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">HCPCS billing unit<\/td>\n<td style=\"padding:12px 16px;color:#374151\">1 unit of J0895 equals 500 mg<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Practices that record doses inside <a href=\"https:\/\/pabau.com\/industry\/iv-therapy-emr-software\/\">IV therapy EMR software<\/a> can feed the administered milligrams straight into the unit calculation. That removes the retyping step where unit counts usually go wrong.<\/p>\n\n\n\n<h2 id=\"h-covered-and-excluded-indications\" class=\"wp-block-heading\">Covered and excluded indications<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Payer coverage for J0895 tracks the FDA-approved indications closely. Bill outside them and the claim is denied, with overpayment recovery possible if an audit follows. The table below shows where the line sits.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4;min-width:200px\">Indication<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Coverage status<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Notes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Chronic iron overload from transfusion-dependent anemia<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Covered by Medicare and most commercial plans<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Serum ferritin and TSAT documentation required<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Thalassemia major, transfusion-dependent<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Covered<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Pair with D56.1 and document transfusion frequency<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Hereditary hemochromatosis<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Covered when phlebotomy is contraindicated<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Must document why phlebotomy is not appropriate<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Acute iron intoxication or poisoning<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Covered for emergency use<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Typically inpatient; pair with a T45.4 code<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Cardiovascular disease chelation<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Not covered by Medicare or most commercial plans<\/td>\n<td style=\"padding:12px 16px;color:#374151\">No national coverage determination; LCD exclusion applies<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Off-label heavy metal chelation for lead or mercury<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Generally not covered under J0895<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Different chelating agents apply; verify with the payer first<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">The cardiovascular chelation exclusion is firm. Medicare has no national coverage determination for chelation as a cardiovascular treatment. Most commercial payers hold the same position in their clinical policy bulletins, including Aetna Clinical Policy Bulletin 0234.<\/p>\n\n\n\n<h2 id=\"h-icd-10-codes-used-with-j0895\" class=\"wp-block-heading\">ICD-10 codes used with J0895<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Every J0895 claim needs a supporting ICD-10-CM diagnosis code that proves medical necessity for iron chelation. Missing or unsupported diagnosis codes drive a large share of J0895 denials. Cross-check your code list each October, when the annual ICD-10-CM update takes effect.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4;min-width:120px\">ICD-10-CM Code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Use with J0895 when\u2026<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">E83.10<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Disorder of iron metabolism, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Documentation does not identify the type of iron overload<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">E83.110<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Hereditary hemochromatosis<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Hereditary disease and phlebotomy is contraindicated<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">E83.111<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Hemochromatosis due to repeated red blood cell transfusions<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Transfusional iron overload, the most common pairing<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D56.1<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Beta thalassemia<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Transfusion-dependent beta-thalassemia needing iron chelation<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D56.0<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Alpha thalassemia<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Transfusion-dependent alpha-thalassemia, less common<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D57.1<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Sickle-cell disease without crisis<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Transfusion-dependent sickle cell with resulting iron overload<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">T45.4XXA<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Poisoning by iron and its compounds, accidental, initial encounter<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Acute iron intoxication, initial treatment episode<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Use the most specific code the record supports. E83.10 is acceptable when documentation does not identify the type, but payers increasingly want specificity. E83.110 and E83.111 both sit under the E83.11 parent, which is not billable on its own.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For a thalassemia patient, code the underlying hematologic condition alongside the iron overload code. Practices on <a href=\"https:\/\/pabau.com\/industry\/metabolic-health-emr\/\">metabolic health software<\/a> can hold both codes against the same treatment plan, so neither drops off the claim.<\/p>\n\n\n\n<h2 id=\"h-how-to-calculate-the-units-you-bill\" class=\"wp-block-heading\">How to calculate the units you bill<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">J0895 is billed per 500 mg, so every 500 mg administered equals one unit. Miscounting units is the single most common cause of J0895 denials. Document the calculation in the clinical record before the claim goes out.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Unit calculation formula:<\/strong> total dose in mg divided by 500 mg equals the units to bill.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4;min-width:160px\">Dose administered<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:center;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Units to bill (J0895)<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Calculation<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">500 mg<\/td>\n<td style=\"padding:12px 16px;text-align:center;color:#374151\">1<\/td>\n<td style=\"padding:12px 16px;color:#374151\">500 \/ 500 = 1<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">1,000 mg<\/td>\n<td style=\"padding:12px 16px;text-align:center;color:#374151\">2<\/td>\n<td style=\"padding:12px 16px;color:#374151\">1,000 \/ 500 = 2<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">1,200 mg<\/td>\n<td style=\"padding:12px 16px;text-align:center;color:#374151\">3<\/td>\n<td style=\"padding:12px 16px;color:#374151\">1,200 \/ 500 = 2.4, rounded up to 3<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">1,500 mg<\/td>\n<td style=\"padding:12px 16px;text-align:center;color:#374151\">3<\/td>\n<td style=\"padding:12px 16px;color:#374151\">1,500 \/ 500 = 3<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">2,000 mg<\/td>\n<td style=\"padding:12px 16px;text-align:center;color:#374151\">4<\/td>\n<td style=\"padding:12px 16px;color:#374151\">2,000 \/ 500 = 4<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">2,500 mg<\/td>\n<td style=\"padding:12px 16px;text-align:center;color:#374151\">5<\/td>\n<td style=\"padding:12px 16px;color:#374151\">2,500 \/ 500 = 5<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Rounding rules:<\/strong> round up to the nearest whole unit when a dose does not divide evenly by 500 mg. The <a href=\"https:\/\/www.cms.gov\/regulations-and-guidance\/guidance\/manuals\/downloads\/clm104c17.pdf\" target=\"_blank\" rel=\"nofollow noopener\">Medicare Claims Processing Manual<\/a>, Chapter 17, sets that rule for fractional drug units. A 1,200 mg dose therefore bills as 3 units, not 2.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Deferoxamine ships in single-dose 500 mg vials, which puts J0895 under the CMS discarded-drug rules. Append JW for the amount discarded from a partially used vial, and JZ when nothing is discarded. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">CMS has edited claims for single-dose container drugs missing both modifiers since October 2023.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Bill only for the amount actually given, and let JW carry the discarded remainder. Most payers also apply a maximum units per day limit that follows FDA dosing guidance, so unusual unit counts trigger automated edits.<\/p>\n\n\n\n<h2 id=\"h-medicare-fee-schedule-and-reimbursement-rates\" class=\"wp-block-heading\">Medicare fee schedule and reimbursement rates<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">CMS pays HCPCS Code J0895 under the Part B drug benefit using the Average Sales Price (ASP) method. Payment equals ASP plus 6%, refreshed each quarter through the <a href=\"https:\/\/www.cms.gov\/medicare\/physician-fee-schedule\/search\/overview\" target=\"_blank\" rel=\"nofollow noopener\">CMS Physician Fee Schedule<\/a> lookup.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">ASP moves with manufacturer pricing and generic competition, so the amount per unit changes four times a year. The same method sets the rate for other Part B infusion drugs, including <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j1364\/\">J1364<\/a>. Verify the current quarter&rsquo;s rate before you estimate reimbursement.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>Check the CMS ASP drug pricing files at the start of each calendar quarter, in January, April, July, and October. The J0895 rate can shift by 10 to 20% between quarters when generic competition intensifies. Build a quarterly rate check into your revenue cycle calendar instead of reusing last quarter&rsquo;s figure.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h3 id=\"h-facility-vs-non-facility-rates\" class=\"wp-block-heading\">Facility vs non-facility rates<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The place of service code on the claim decides which rate applies. Most infusion practices bill the non-facility office rate, which is the higher of the two. Hospital outpatient departments and ambulatory infusion centers bill the facility rate, because the facility&rsquo;s OPPS payment already covers the practice expense.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4;min-width:200px\">Setting<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Place of service codes<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Rate type<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Physician office or infusion suite<\/td>\n<td style=\"padding:12px 16px;color:#374151\">POS 11<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Non-facility, the higher rate<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Hospital outpatient department<\/td>\n<td style=\"padding:12px 16px;color:#374151\">POS 22<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Facility rate<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Ambulatory infusion center<\/td>\n<td style=\"padding:12px 16px;color:#374151\">POS 22 or 19<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Facility rate<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Home, self-administered or homecare agency<\/td>\n<td style=\"padding:12px 16px;color:#374151\">POS 12<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Non-facility rate; DME rules may apply<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Check the ASC status for J0895 against current CMS ASC payment indicator files each year, because the indicator can change with OPPS and ASC updates. Third-party sources show an active ASC indicator, so confirm it against CMS data before you bill in that setting.<\/p>\n\n\n\n<h2 id=\"h-payer-coverage-policies\" class=\"wp-block-heading\">Payer coverage policies<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Coverage policies for iron chelation vary by payer and plan, but three themes repeat. Payers support transfusion-dependent iron overload, restrict hemochromatosis coverage to patients who cannot tolerate phlebotomy, and exclude cardiovascular chelation. Check the applicable Local Coverage Determination (LCD) before you bill a Medicare patient.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4;min-width:140px\">Payer<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Coverage position<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Key exclusion<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Medicare (CMS)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Covers iron overload and thalassemia under LCD guidelines<\/td>\n<td style=\"padding:12px 16px;color:#374151\">No coverage for cardiovascular chelation<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Aetna (CPB 0234)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Covers medically necessary iron chelation for covered diagnoses<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Excludes cardiovascular and heavy-metal chelation<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">BCBS plans<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Generally follow AMA and CMS guidance for iron chelation<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Policy varies by regional plan; verify before billing<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Medicaid<\/td>\n<td style=\"padding:12px 16px;color:#374151\">State-specific; most cover the approved diagnoses<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Prior authorization is often required and varies by state<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Cite the specific policy document in your notes, and treat every policy as temporary. Coverage that applied last year may not apply today. Confirm coverage for each new patient before the drug is administered.<\/p>\n\n\n\n<h2 id=\"h-billing-modifiers-for-j0895\" class=\"wp-block-heading\">Billing modifiers for J0895<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Modifiers on a J0895 claim do two jobs. They tell the payer how the drug was given, and they flag the clinical circumstances that decide whether the claim gets paid. A wrong or missing modifier sends the claim to the denial queue.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4;min-width:100px\">Modifier<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">When to use with J0895<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">JA<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Administered intravenously<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Required by many payers when the drug is given as an IV infusion<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">JB<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Administered subcutaneously<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Use for the overnight subcutaneous pump protocol<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">JW<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Drug amount discarded and not administered<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Report the discarded milligrams from a partially used single-dose vial<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">JZ<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Zero drug amount discarded<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Attest that the full vial was administered with nothing wasted<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">59<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Distinct procedural service<\/td>\n<td style=\"padding:12px 16px;color:#374151\">When J0895 shares a claim date with other infusion J-codes<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">76<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Repeat procedure by the same physician<\/td>\n<td style=\"padding:12px 16px;color:#374151\">When a second infusion session happens the same day<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">GY<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Item or service statutorily excluded from Medicare<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Billing a non-covered indication such as cardiovascular chelation<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">GZ<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Expected to be denied as not medically necessary<\/td>\n<td style=\"padding:12px 16px;color:#374151\">No ABN is on file but a denial is anticipated<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<h2 id=\"h-the-buy-and-bill-workflow\" class=\"wp-block-heading\">The buy-and-bill workflow<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Deferoxamine mesylate is a physician-administered drug billed under the buy-and-bill model. The practice buys the drug, administers it, then bills the payer for both the drug and the administration service. An error anywhere in that chain surfaces later as a claim problem.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/pabau.com\/features\/claims-management-software\/\">Claims management software<\/a> that links drug inventory to claim generation keeps the milligrams administered and the units billed in step. <a href=\"https:\/\/pabau.com\/features\/inventory-management-software\/\">Stock tracking<\/a> logs the vial and lot number against the treatment note at the same time.<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Acquire the drug:<\/strong> buy deferoxamine mesylate from a wholesaler or specialty pharmacy. Record the NDC number, lot number, and quantity received.<\/li>\n\n\n\n<li><strong>Verify eligibility and coverage:<\/strong> confirm coverage for the specific indication before each infusion session, and obtain prior authorization where required.<\/li>\n\n\n\n<li><strong>Administer and document:<\/strong> record the dose in mg, the route, start and stop times, and the supervising clinician.<\/li>\n\n\n\n<li><strong>Calculate billing units:<\/strong> divide total mg administered by 500 and round up. Document the calculation in the claim note.<\/li>\n\n\n\n<li><strong>Select modifiers:<\/strong> apply JA or JB for route, JW or JZ for discard, plus anything else the payer requires.<\/li>\n\n\n\n<li><strong>Submit with the NDC crosswalk:<\/strong> many payers want the 11-digit NDC on the claim line alongside J0895, in 5-4-2 format without hyphens.<\/li>\n\n\n\n<li><strong>Post payment and reconcile:<\/strong> compare the remittance to the expected ASP plus 6% rate. Investigate any adjustment code that suggests a unit mismatch.<\/li>\n<\/ol>\n\n\n\n<h3 id=\"h-ndc-to-hcpcs-crosswalk-for-deferoxamine-mesylate\" class=\"wp-block-heading\">NDC to HCPCS crosswalk for deferoxamine mesylate<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The NDC number identifies the exact commercial product dispensed. Submitting the wrong NDC, or leaving it off when a payer requires it, gets the claim rejected before adjudication. CMS publishes a quarterly drug HCPCS crosswalk file, and manufacturer NDCs change when products are reformulated or redistributed.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4;min-width:160px\">Product and manufacturer<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">NDC (verify current)<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">HCPCS Code<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Desferal (Novartis), single 500 mg vial<\/td>\n<td style=\"padding:12px 16px;color:#374151\">0078-0467-61<\/td>\n<td style=\"padding:12px 16px;color:#374151\">J0895<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Desferal (Novartis), carton of four 500 mg vials<\/td>\n<td style=\"padding:12px 16px;color:#374151\">0078-0467-91<\/td>\n<td style=\"padding:12px 16px;color:#374151\">J0895<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Deferoxamine mesylate generic, 500 mg vial<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Multiple NDCs; verify via the CMS ASP crosswalk file<\/td>\n<td style=\"padding:12px 16px;color:#374151\">J0895<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">The 11-digit claim format is 5-4-2 without hyphens, so 0078-0467-61 goes on the line as 00780046761. The FDA&rsquo;s DailyMed listing carries the current <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=a7174843-5965-49fc-b842-f7eff7b48bbc\" target=\"_blank\" rel=\"nofollow noopener\">Desferal package NDCs<\/a>. Check every NDC against the current CMS quarterly ASP file before you submit.<\/p>\n\n\n\n<h2 id=\"h-common-billing-errors-and-denial-prevention\" class=\"wp-block-heading\">Common billing errors and denial prevention<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Most J0895 denials trace back to a short list of predictable errors. Catching them before submission beats working a denial queue afterward.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Wrong unit count:<\/strong> billing 1 unit for a 2,000 mg dose is the most common error. Divide the dose by 500 and round up before submitting.<\/li>\n\n\n\n<li><strong>Non-covered diagnosis code:<\/strong> a cardiovascular or general chelation diagnosis triggers automatic denial. Use only ICD-10 codes that map to covered iron overload indications.<\/li>\n\n\n\n<li><strong>Missing JW or JZ:<\/strong> single-dose container drugs need one of the two on every claim line. Neither one present is an automatic edit.<\/li>\n\n\n\n<li><strong>Missing or invalid NDC:<\/strong> payers that require the NDC on the claim line reject without it. Check payer billing requirements before the first submission.<\/li>\n\n\n\n<li><strong>Wrong route modifier:<\/strong> applying JA when the drug went in subcutaneously, or omitting the route modifier entirely, causes adjudication errors.<\/li>\n\n\n\n<li><strong>No prior authorization:<\/strong> Medicaid and some commercial plans require it for iron chelation. Submitting without it is an immediate denial.<\/li>\n\n\n\n<li><strong>Outdated rate expectations:<\/strong> expecting last quarter&rsquo;s rate after ASP has moved causes reconciliation confusion and delayed write-offs.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-how-to-document-medical-necessity\" class=\"wp-block-heading\">How to document medical necessity<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Payers auditing J0895 claims look for lab values and clinical findings in the record, not just a diagnosis code on the claim. Serum ferritin and transferrin saturation are the two numbers they expect to see trended over time.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Structured <a href=\"https:\/\/pabau.com\/features\/medical-records-management\/\">patient records<\/a> make that trend easy to produce on request. Pulling the same values out of scanned PDFs costs a coder hours. <a href=\"https:\/\/pabau.com\/features\/medical-lab-software\/\">Lab result tracking<\/a> keeps every ferritin reading attached to the visit that prompted it.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The baseline matters just as much. <a href=\"https:\/\/pabau.com\/features\/patient-intake-software\/\">Digital intake forms<\/a> capture history, contraindications, and prior therapy before the first infusion goes in.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/billing_codes\/hcpcs-code-j0895\/comprehensive-patient-records.webp\" alt=\"Pabau patient record with an activity timeline of scheduled and completed contacts\"\/><figcaption class=\"wp-element-caption\"><em>Pabau keeps ferritin results, consent, and every patient contact on one timeline, which is exactly what a payer asks for during an audit.<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:35px;width:800px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Confirm the qualifying diagnosis:<\/strong> document the underlying condition with clinical history and any genetic or pathology confirmation.<\/li>\n\n\n\n<li><strong>Record baseline and ongoing labs:<\/strong> serum ferritin and transferrin saturation values belong in the record at the start of therapy and at regular intervals.<\/li>\n\n\n\n<li><strong>Document the treatment rationale:<\/strong> for hemochromatosis patients, explain why phlebotomy is contraindicated, such as anemia or poor venous access.<\/li>\n\n\n\n<li><strong>Note dose and route explicitly:<\/strong> the record must show mg administered, route, and infusion duration. An entry reading \u00ab\u00a0chelation administered\u00a0\u00bb will not survive an audit.<\/li>\n\n\n\n<li><strong>Retain the physician order:<\/strong> a signed order for each chelation course, with frequency and dose, supports medical necessity on review.<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">An <a href=\"https:\/\/pabau.com\/templates\/iv-therapy-patient-intake\/\">IV therapy intake form<\/a> gives you a repeatable structure for that baseline assessment. When a payer wants written confirmation of the qualifying condition, a <a href=\"https:\/\/pabau.com\/templates\/diagnosis-letter-from-doctor\/\">diagnosis letter<\/a> template saves the physician drafting one from scratch.<\/p>\n\n\n\n<h2 id=\"h-related-hcpcs-and-cpt-codes\" class=\"wp-block-heading\">Related HCPCS and CPT codes<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">J0895 rarely appears on a claim by itself. Iron chelation infusions need administration codes, and the underlying condition often brings related drug therapies with it. Cross-referencing these codes keeps the claim aligned with the service delivered.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4;min-width:120px\">Code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Relationship to J0895<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">CPT 96365<\/td>\n<td style=\"padding:12px 16px;color:#374151\">IV infusion, therapeutic or diagnostic, initial up to 1 hour<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Administration code for IV deferoxamine, billed alongside J0895<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">CPT 96366<\/td>\n<td style=\"padding:12px 16px;color:#374151\">IV infusion, each additional hour<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Add-on for IV infusions running past the first hour<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">CPT 96369<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Subcutaneous infusion, initial up to 1 hour, including pump set-up<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Administration code for the overnight subcutaneous pump protocol<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">CPT 96370<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Subcutaneous infusion, each additional hour<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Add-on for each additional hour on the subcutaneous pump<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">CPT 99213\/99214<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Office or other outpatient visit, established patient<\/td>\n<td style=\"padding:12px 16px;color:#374151\">E\/M service billed the same day when a separately identifiable visit occurs<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\"><a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j0600\/\">J0600<\/a><\/td>\n<td style=\"padding:12px 16px;color:#374151\">Injection, edetate calcium disodium, up to 1000 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">A different chelating agent for lead poisoning; it never maps to J0895<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">HCPCS Q9977<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Extemporaneously compounded drug, not otherwise classified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">For a compounded deferoxamine formulation that does not map to J0895<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Report the administration code that matches the route actually used. Billing 96365 for an overnight subcutaneous pump is a route mismatch, and payers catch it against the JB modifier on the drug line.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>When J0895 shares a claim with an infusion administration code, append modifier 59 to the administration code rather than to J0895. Every claim line for a single-dose container drug also needs JW or JZ. Review each payer&rsquo;s drug billing policy once a year.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-how-claims-management-software-keeps-j0895-claims-clean\" class=\"wp-block-heading\">How claims management software keeps J0895 claims clean<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Most practices calculate J0895 units by hand. Someone reads the infusion note, divides milligrams by 500, rounds, then types a number into the claim. The dose lives in one system and the claim in another, so a transcription slip stays invisible until the denial arrives.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Practice management software like Pabau keeps the treatment note, the drug record, and the invoice in one place. The milligrams recorded at the chair are the milligrams the claim is built from. The unit count comes out of the record instead of someone&rsquo;s mental arithmetic.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau also stores payer rules per plan, so a cardiovascular diagnosis on a chelation claim gets flagged before submission rather than after. Lab results, consent, and the physician order sit on the same record, which is the first thing an auditor asks for.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/pabau.com\/case-studies\/esteem-life-medical-group\/\">Esteem Life Medical Group<\/a> runs patient records, charting, and reporting in Pabau for exactly that reason. Every subscription includes every feature, so none of it sits behind a higher tier.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/billing_codes\/hcpcs-code-j0895\/automate-claims-through-healthcode.webp\" alt=\"Pabau checkout screen next to a completed insurer invoice\"\/><figcaption class=\"wp-element-caption\"><em>Pabau builds the invoice from the checkout record, so the drug, the units, and the payer line up before the claim leaves the practice.<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:35px;width:800px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n        <div id=\"book_a_demo\">\n            <div class=\"left-side\">\n                <div class=\"logo\">\n                    <img decoding=\"async\"\n                        src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Logo.svg\"\n                        alt=\"Logo\"\n                        loading=\"lazy\"\n                    \/>\n                <\/div>\n\n                <h3 class=\"heading\">\n                    Get J0895 units right before you submit                <\/h3>\n\n                <p class=\"description\">\n                    Pabau links the dose recorded at the chair to the units on the claim, and flags payer rules for iron chelation before submission. Fewer unit errors means fewer reworked claims for your billing team.                <\/p>\n\n                <div class=\"button-group\">\n                    <a href=\"\/book-demo\/\" class=\"btn btn-scale-effect btn-cta-color btn-md\">\n                        <span class=\"btn-text\">Book a demo<\/span>\n                        <div class=\"btn-icon btn-icon-right\" aria-hidden=\"true\">\n                            <svg\n                                width=\"14\"\n                                height=\"12\"\n                                viewBox=\"0 0 14 12\"\n                                fill=\"none\"\n                                xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\n                            >\n                                <path\n                                    d=\"M0.75 4.77295C0.335786 4.77295 0 5.10874 0 5.52295C0 5.93716 0.335786 6.27295 0.75 6.27295V5.52295V4.77295ZM13.2803 6.05328C13.5732 5.76039 13.5732 5.28551 13.2803 4.99262L8.50736 0.219648C8.21447 -0.073245 7.73959 -0.073245 7.4467 0.219648C7.15381 0.512542 7.15381 0.987415 7.4467 1.28031L11.6893 5.52295L7.4467 9.76559C7.15381 10.0585 7.15381 10.5334 7.4467 10.8263C7.73959 11.1191 8.21447 11.1191 8.50736 10.8263L13.2803 6.05328ZM0.75 5.52295V6.27295L12.75 6.27295V5.52295V4.77295L0.75 4.77295V5.52295Z\"\n                                    fill=\"currentColor\"\n                                ><\/path>\n                            <\/svg>\n                        <\/div>\n                    <\/a>\n                <\/div>\n            <\/div>\n\n            <div class=\"right-side\">\n                <img decoding=\"async\"\n                    src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Home-Page-Concept-4.webp\"\n                    alt=\"Pabau claims management dashboard\"\n                    loading=\"lazy\"\n                \/>\n            <\/div>\n        <\/div>\n        \n\n\n<h2 id=\"h-conclusion\" class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">J0895 looks simple and denies often, usually because of the unit count rather than the clinical picture. Fix the unit math, pair it with a diagnosis payers accept, and most claims pay first time.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Two habits do most of the work. Verify the current quarter&rsquo;s ASP rate before you quote a number. Check the diagnosis against the coverage table before the drug goes in the line.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Confirming coverage after the infusion is the expensive version of this article. The drug is already bought and already given, and the write-off lands on your practice.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau keeps the dose, the diagnosis, and the claim on one record, so those checks happen before submission instead of after. <a href=\"https:\/\/pabau.com\/book-demo\/\">Book a demo<\/a> to see how Pabau handles J0895 and other physician-administered drug billing.<\/p>\n\n\n        <div id=\"expert_picks\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/11\/Expert-Picks.svg\" alt=\"Continue your research\" height=\"42\" width=\"42\">\n                                <h3>Continue your research<\/h3>\n            <\/div>\n            <div class=\"content\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Billing the other chelating agent?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j0600\/\">HCPCS Code J0600<\/a> covers edetate calcium disodium, which carries its own unit math and coverage rules.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Running other Part B infusion drugs?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j1322\/\">HCPCS Code J1322<\/a> walks through weight-based dosing and unit calculation for a weekly enzyme replacement infusion.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Losing claims to missing prior auth?<\/strong> The <a href=\"https:\/\/pabau.com\/templates\/medical-prior-authorization-form\/\">medical prior authorization form<\/a> gives you a reusable structure for the requests payers keep sending back.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Weighing a clearinghouse against a full platform?<\/strong> <a href=\"https:\/\/pabau.com\/blog\/claims-management-software-pabau-vs-waystar\/\">Claims management software: Pabau vs. Waystar<\/a> compares what each one handles across the revenue cycle.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Need another J-code worked example?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j0153\/\">HCPCS Code J0153<\/a> shows how a 1 mg billing unit changes the arithmetic on every claim line.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-frequently-asked-questions\" class=\"wp-block-heading\">Frequently asked questions<\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1786603295225\"><h3 class=\"schema-faq-question\">What is HCPCS Code J0895 used for?<\/h3> <p class=\"schema-faq-answer\">J0895 is the HCPCS Level II billing code for injection of deferoxamine mesylate, 500 mg. Deferoxamine is an iron chelator used for chronic iron overload from transfusion-dependent anemia, hereditary hemochromatosis when phlebotomy is contraindicated, and acute iron intoxication. Each billing unit represents 500 mg of drug administered.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786603295226\"><h3 class=\"schema-faq-question\">How many units of J0895 do I bill for a 1,500 mg dose?<\/h3> <p class=\"schema-faq-answer\">Bill 3 units. J0895 represents 500 mg per unit, so divide the total dose by 500: 1,500 divided by 500 equals 3 units. Round up to the next whole unit when a dose does not divide evenly, as the Medicare Claims Processing Manual requires. A 1,200 mg dose bills as 3 units, not 2.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786603295231\"><h3 class=\"schema-faq-question\">Does J0895 need the JW or JZ modifier?<\/h3> <p class=\"schema-faq-answer\">Yes. Deferoxamine mesylate comes in single-dose vials, so every J0895 claim line needs one of the two. Use JW to report the milligrams discarded from a partially used vial, and JZ to attest that nothing was discarded. Claims for single-dose container drugs that carry neither modifier fail CMS edits.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786603295227\"><h3 class=\"schema-faq-question\">Does Medicare cover J0895 for cardiovascular chelation therapy?<\/h3> <p class=\"schema-faq-answer\">No. Medicare has no national coverage determination for chelation therapy as a cardiovascular treatment, and Medicare Administrative Contractor LCDs exclude the indication. Claims submitted with a cardiovascular diagnosis will be denied. If a patient insists on the service, issue an Advance Beneficiary Notice and append modifier GY before administering.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786603295228\"><h3 class=\"schema-faq-question\">What is the Medicare reimbursement rate for J0895?<\/h3> <p class=\"schema-faq-answer\">Medicare reimburses J0895 at ASP plus 6%, recalculated each calendar quarter. Because deferoxamine mesylate faces generic competition, the rate moves between quarters. Verify the current rate with the CMS Physician Fee Schedule lookup at the start of each quarter, before you estimate patient cost-sharing or expected revenue.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786603295229\"><h3 class=\"schema-faq-question\">Is J0895 covered in an ambulatory surgical center setting?<\/h3> <p class=\"schema-faq-answer\">J0895 carries an ASC payment indicator in most CMS payment files, but the indicator can change with annual OPPS and ASC updates. Verify the current ASC status directly from CMS ASC payment indicator files before billing in that setting. Third-party sources often lag behind the CMS quarterly updates.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786603295230\"><h3 class=\"schema-faq-question\">Is chelation therapy for hemochromatosis covered under J0895?<\/h3> <p class=\"schema-faq-answer\">Yes, with conditions. Medicare and most commercial payers cover deferoxamine mesylate for hereditary hemochromatosis when therapeutic phlebotomy is contraindicated. Severe anemia and poor venous access are the usual reasons. The record must document the specific contraindication and include supporting lab values. Code it as E83.110 rather than the non-billable E83.11 parent.<\/p> <\/div> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>HCPCS Code J0895 is the billing code for an injection of deferoxamine mesylate, 500 mg. One unit equals 500 mg of drug administered, so the dose drives the unit count on every claim. Deferoxamine is an iron chelator, and payers cover it for a narrow list of iron overload diagnoses. Medicare pays it under Part [&hellip;]<\/p>\n","protected":false},"author":83,"featured_media":177194,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_linkdex":"85","_yoast_wpseo_content_score":"30","_yoast_wpseo_is_cornerstone":"","_yoast_wpseo_keywordsynonyms":"[\"\",\"\",\"\",\"\"]","_yoast_wpseo_focuskw_text_input":"","_seo_original_html":"","footnotes":""},"categories":[1433,1548,1115,1117],"tags":[1439,1582,1619,1163,3044],"class_list":["post-177197","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-billing-codes","category-hcpcs","category-iv-therapy","category-metabolic-health","tag-claims-management","tag-hcpcs","tag-hcpcs-billing","tag-medical-billing","tag-medicare-part-b"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.2 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>HCPCS Code J0895: How to bill deferoxamine units correctly<\/title>\n<meta name=\"description\" content=\"HCPCS Code J0895 bills one unit per 500 mg, rounded up, and every claim line needs JW or JZ. Medicare excludes cardiovascular chelation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HCPCS Code J0895: How to bill deferoxamine units correctly\" \/>\n<meta property=\"og:description\" content=\"HCPCS Code J0895 bills one unit per 500 mg, rounded up, and every claim line needs JW or JZ. Medicare excludes cardiovascular chelation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/\" \/>\n<meta property=\"og:site_name\" content=\"Pabau\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Pabau\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-13T08:50:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-13T08:50:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0895.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Anja Dodevska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:site\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anja Dodevska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"16 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/\"},\"author\":{\"name\":\"Anja Dodevska\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/person\\\/f2e43b25ed02313e8781f0f4507398b9\"},\"headline\":\"HCPCS Code J0895: Injection, deferoxamine mesylate, 500 mg\",\"datePublished\":\"2026-08-13T08:50:06+00:00\",\"dateModified\":\"2026-08-13T08:50:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/\"},\"wordCount\":3238,\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0895.webp\",\"keywords\":[\"claims management\",\"Hcpcs\",\"Hcpcs Billing\",\"Medical Billing\",\"Medicare Part B\"],\"articleSection\":[\"Billing Codes\",\"HCPCS\",\"IV Therapy\",\"Metabolic Health\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"FAQPage\"],\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/\",\"name\":\"HCPCS Code J0895: How to bill deferoxamine units correctly\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0895.webp\",\"datePublished\":\"2026-08-13T08:50:06+00:00\",\"dateModified\":\"2026-08-13T08:50:08+00:00\",\"description\":\"HCPCS Code J0895 bills one unit per 500 mg, rounded up, and every claim line needs JW or JZ. Medicare excludes cardiovascular chelation.\",\"mainEntity\":[{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295225\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295226\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295231\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295227\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295228\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295229\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295230\"}],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0895.webp\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j0895.webp\",\"width\":1200,\"height\":630},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/\",\"name\":\"Pabau\",\"description\":\"Clinic Software for your Business | Go Paperless Today\",\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pabau.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#organization\",\"name\":\"Pabau\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"width\":736,\"height\":195,\"caption\":\"Pabau\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Pabau\\\/\",\"https:\\\/\\\/x.com\\\/pabaucrm\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pabau-ltd\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pabausoftware\\\/\"],\"description\":\"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.\",\"foundingDate\":\"2011-10-20\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/#\\\/schema\\\/person\\\/f2e43b25ed02313e8781f0f4507398b9\",\"name\":\"Anja Dodevska\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg\",\"caption\":\"Anja Dodevska\"},\"description\":\"Anja Dodevska writes about healthcare, dermatology, and the day-to-day realities of running a medical practice for Pabau. She enjoys breaking down complex topics into clear, accessible content and has a soft spot for the often-overlooked aspects of clinic life. When she's not writing, she's exploring cafes, walking her dog, or spending time with friends and family.\",\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/blog\\\/author\\\/anja-dodevska\\\/\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295225\",\"position\":1,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295225\",\"name\":\"What is HCPCS Code J0895 used for?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"J0895 is the HCPCS Level II billing code for injection of deferoxamine mesylate, 500 mg. Deferoxamine is an iron chelator used for chronic iron overload from transfusion-dependent anemia, hereditary hemochromatosis when phlebotomy is contraindicated, and acute iron intoxication. Each billing unit represents 500 mg of drug administered.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295226\",\"position\":2,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295226\",\"name\":\"How many units of J0895 do I bill for a 1,500 mg dose?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Bill 3 units. J0895 represents 500 mg per unit, so divide the total dose by 500: 1,500 divided by 500 equals 3 units. Round up to the next whole unit when a dose does not divide evenly, as the Medicare Claims Processing Manual requires. A 1,200 mg dose bills as 3 units, not 2.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295231\",\"position\":3,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295231\",\"name\":\"Does J0895 need the JW or JZ modifier?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes. Deferoxamine mesylate comes in single-dose vials, so every J0895 claim line needs one of the two. Use JW to report the milligrams discarded from a partially used vial, and JZ to attest that nothing was discarded. Claims for single-dose container drugs that carry neither modifier fail CMS edits.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295227\",\"position\":4,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295227\",\"name\":\"Does Medicare cover J0895 for cardiovascular chelation therapy?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. Medicare has no national coverage determination for chelation therapy as a cardiovascular treatment, and Medicare Administrative Contractor LCDs exclude the indication. Claims submitted with a cardiovascular diagnosis will be denied. If a patient insists on the service, issue an Advance Beneficiary Notice and append modifier GY before administering.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295228\",\"position\":5,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295228\",\"name\":\"What is the Medicare reimbursement rate for J0895?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Medicare reimburses J0895 at ASP plus 6%, recalculated each calendar quarter. Because deferoxamine mesylate faces generic competition, the rate moves between quarters. Verify the current rate with the CMS Physician Fee Schedule lookup at the start of each quarter, before you estimate patient cost-sharing or expected revenue.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295229\",\"position\":6,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295229\",\"name\":\"Is J0895 covered in an ambulatory surgical center setting?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"J0895 carries an ASC payment indicator in most CMS payment files, but the indicator can change with annual OPPS and ASC updates. Verify the current ASC status directly from CMS ASC payment indicator files before billing in that setting. Third-party sources often lag behind the CMS quarterly updates.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295230\",\"position\":7,\"url\":\"https:\\\/\\\/pabau.com\\\/fr\\\/procedure-codes\\\/hcpcs-code-j0895\\\/#faq-question-1786603295230\",\"name\":\"Is chelation therapy for hemochromatosis covered under J0895?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, with conditions. Medicare and most commercial payers cover deferoxamine mesylate for hereditary hemochromatosis when therapeutic phlebotomy is contraindicated. Severe anemia and poor venous access are the usual reasons. The record must document the specific contraindication and include supporting lab values. Code it as E83.110 rather than the non-billable E83.11 parent.\",\"inLanguage\":\"fr-FR\"},\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"HCPCS Code J0895: How to bill deferoxamine units correctly","description":"HCPCS Code J0895 bills one unit per 500 mg, rounded up, and every claim line needs JW or JZ. Medicare excludes cardiovascular chelation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/","og_locale":"fr_FR","og_type":"article","og_title":"HCPCS Code J0895: How to bill deferoxamine units correctly","og_description":"HCPCS Code J0895 bills one unit per 500 mg, rounded up, and every claim line needs JW or JZ. Medicare excludes cardiovascular chelation.","og_url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/","og_site_name":"Pabau","article_publisher":"https:\/\/www.facebook.com\/Pabau\/","article_published_time":"2026-08-13T08:50:06+00:00","article_modified_time":"2026-08-13T08:50:08+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0895.webp","type":"image\/webp"}],"author":"Anja Dodevska","twitter_card":"summary_large_image","twitter_creator":"@pabaucrm","twitter_site":"@pabaucrm","twitter_misc":{"\u00c9crit par":"Anja Dodevska","Dur\u00e9e de lecture estim\u00e9e":"16 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#article","isPartOf":{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/"},"author":{"name":"Anja Dodevska","@id":"https:\/\/pabau.com\/fr\/#\/schema\/person\/f2e43b25ed02313e8781f0f4507398b9"},"headline":"HCPCS Code J0895: Injection, deferoxamine mesylate, 500 mg","datePublished":"2026-08-13T08:50:06+00:00","dateModified":"2026-08-13T08:50:08+00:00","mainEntityOfPage":{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/"},"wordCount":3238,"publisher":{"@id":"https:\/\/pabau.com\/fr\/#organization"},"image":{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0895.webp","keywords":["claims management","Hcpcs","Hcpcs Billing","Medical Billing","Medicare Part B"],"articleSection":["Billing Codes","HCPCS","IV Therapy","Metabolic Health"],"inLanguage":"fr-FR"},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/","url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/","name":"HCPCS Code J0895: How to bill deferoxamine units correctly","isPartOf":{"@id":"https:\/\/pabau.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#primaryimage"},"image":{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0895.webp","datePublished":"2026-08-13T08:50:06+00:00","dateModified":"2026-08-13T08:50:08+00:00","description":"HCPCS Code J0895 bills one unit per 500 mg, rounded up, and every claim line needs JW or JZ. Medicare excludes cardiovascular chelation.","mainEntity":[{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295225"},{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295226"},{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295231"},{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295227"},{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295228"},{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295229"},{"@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295230"}],"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#primaryimage","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0895.webp","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j0895.webp","width":1200,"height":630},{"@type":"WebSite","@id":"https:\/\/pabau.com\/fr\/#website","url":"https:\/\/pabau.com\/fr\/","name":"Pabau","description":"Clinic Software for your Business | Go Paperless Today","publisher":{"@id":"https:\/\/pabau.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pabau.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/pabau.com\/fr\/#organization","name":"Pabau","url":"https:\/\/pabau.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/pabau.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","width":736,"height":195,"caption":"Pabau"},"image":{"@id":"https:\/\/pabau.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Pabau\/","https:\/\/x.com\/pabaucrm","https:\/\/www.linkedin.com\/company\/pabau-ltd\/","https:\/\/www.instagram.com\/pabausoftware\/"],"description":"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.","foundingDate":"2011-10-20","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"}},{"@type":"Person","@id":"https:\/\/pabau.com\/fr\/#\/schema\/person\/f2e43b25ed02313e8781f0f4507398b9","name":"Anja Dodevska","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg","caption":"Anja Dodevska"},"description":"Anja Dodevska writes about healthcare, dermatology, and the day-to-day realities of running a medical practice for Pabau. She enjoys breaking down complex topics into clear, accessible content and has a soft spot for the often-overlooked aspects of clinic life. When she's not writing, she's exploring cafes, walking her dog, or spending time with friends and family.","url":"https:\/\/pabau.com\/fr\/blog\/author\/anja-dodevska\/"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295225","position":1,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295225","name":"What is HCPCS Code J0895 used for?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"J0895 is the HCPCS Level II billing code for injection of deferoxamine mesylate, 500 mg. Deferoxamine is an iron chelator used for chronic iron overload from transfusion-dependent anemia, hereditary hemochromatosis when phlebotomy is contraindicated, and acute iron intoxication. Each billing unit represents 500 mg of drug administered.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295226","position":2,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295226","name":"How many units of J0895 do I bill for a 1,500 mg dose?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Bill 3 units. J0895 represents 500 mg per unit, so divide the total dose by 500: 1,500 divided by 500 equals 3 units. Round up to the next whole unit when a dose does not divide evenly, as the Medicare Claims Processing Manual requires. A 1,200 mg dose bills as 3 units, not 2.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295231","position":3,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295231","name":"Does J0895 need the JW or JZ modifier?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Yes. Deferoxamine mesylate comes in single-dose vials, so every J0895 claim line needs one of the two. Use JW to report the milligrams discarded from a partially used vial, and JZ to attest that nothing was discarded. Claims for single-dose container drugs that carry neither modifier fail CMS edits.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295227","position":4,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295227","name":"Does Medicare cover J0895 for cardiovascular chelation therapy?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"No. Medicare has no national coverage determination for chelation therapy as a cardiovascular treatment, and Medicare Administrative Contractor LCDs exclude the indication. Claims submitted with a cardiovascular diagnosis will be denied. If a patient insists on the service, issue an Advance Beneficiary Notice and append modifier GY before administering.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295228","position":5,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295228","name":"What is the Medicare reimbursement rate for J0895?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Medicare reimburses J0895 at ASP plus 6%, recalculated each calendar quarter. Because deferoxamine mesylate faces generic competition, the rate moves between quarters. Verify the current rate with the CMS Physician Fee Schedule lookup at the start of each quarter, before you estimate patient cost-sharing or expected revenue.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295229","position":6,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295229","name":"Is J0895 covered in an ambulatory surgical center setting?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"J0895 carries an ASC payment indicator in most CMS payment files, but the indicator can change with annual OPPS and ASC updates. Verify the current ASC status directly from CMS ASC payment indicator files before billing in that setting. Third-party sources often lag behind the CMS quarterly updates.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"},{"@type":"Question","@id":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295230","position":7,"url":"https:\/\/pabau.com\/fr\/procedure-codes\/hcpcs-code-j0895\/#faq-question-1786603295230","name":"Is chelation therapy for hemochromatosis covered under J0895?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Yes, with conditions. Medicare and most commercial payers cover deferoxamine mesylate for hereditary hemochromatosis when therapeutic phlebotomy is contraindicated. Severe anemia and poor venous access are the usual reasons. The record must document the specific contraindication and include supporting lab values. Code it as E83.110 rather than the non-billable E83.11 parent.","inLanguage":"fr-FR"},"inLanguage":"fr-FR"}]}},"yoast":{"focus_keyword":"HCPCS Code J0895","seo_title":"HCPCS Code J0895: How to bill deferoxamine units correctly","meta_description":"HCPCS Code J0895 bills one unit per 500 mg, rounded up, and every claim line needs JW or JZ. Medicare excludes cardiovascular chelation.","content_score":"30","is_cornerstone":"","related_keyphrases":[{"keyword":"deferoxamine mesylate injection billing","score":72},{"keyword":"iron chelation therapy billing","score":61},{"keyword":"J0895 fee schedule","score":61}]},"_links":{"self":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts\/177197","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/users\/83"}],"replies":[{"embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/comments?post=177197"}],"version-history":[{"count":3,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts\/177197\/revisions"}],"predecessor-version":[{"id":177510,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/posts\/177197\/revisions\/177510"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/media\/177194"}],"wp:attachment":[{"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/media?parent=177197"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/categories?post=177197"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pabau.com\/fr\/wp-json\/wp\/v2\/tags?post=177197"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}